ZIYODA MUMINOVA,SHERMATOV ABDUKODIR OBIDJON UGLI ,HAIDEER M. ALABDELI,ANTONY GOMEZ ,DR. D KALIDOSS
DOI: https://doi.org/HIV, HSV, and influenza are just a few of the viral infections that have plagued humans for ages and claimed millions of lives worldwide. However, because the majority of viral viruses continue to be resistant to numerous medical treatments, there are currently few effective medications available to treat infectious disorders. Many secondary metabolites from marine microbes that have antiviral qualities have been well documented up to this point. The viable antiviral compounds of marine microorganisms over the last decade are presented here. Additionally, the compounds' origins, bioactivities, and structures were explained. The most varied habitat for a wide variety of organisms is the ocean. Numerous amazing traits and bioactive compounds of medicinal importance are produced by creatures that thrive in the harsh circumstances of the sea. These metabolites have several immunomodulatory properties, including anti-inflammatory and antioxidant properties, and are active even at very low doses. Despite the development of COVID-19 vaccinations and ongoing medication research, there is currently no viable treatment for this deadly virus. To develop the tailored medication for COVID-19, researchers are delving deeply into the extensive database of bioactive compounds. It is challenging to apply the repurposed medications against the rapidly changing virus, which has shifting symptoms and a different route of transmission.
